Related Experiment Video

Updated: Jun 17, 2026

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
10:21

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test

Published on: September 22, 2023

Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials

Carlos M Ferrario1, John M Flack, John E Strobeck

  • 1Hypertension and Vascular Research Center, Wake Forest University Medical Center, Winston-Salem, North Carolina, USA. cferrari@wfubmc.edu

Therapeutic Advances in Cardiovascular Disease
|January 1, 2010
PubMed

Insights

Using impedance cardiography (ICG) to guide treatment significantly improves blood pressure control in hypertensive patients. This method, which provides hemodynamic information, more than doubles the likelihood of achieving target blood pressure goals.

Area of Science:

  • Cardiology
  • Clinical Pharmacology
  • Biomedical Engineering

Background:

  • Hypertension affects millions, leading to significant healthcare costs despite existing treatments.
  • Current hypertension control rates remain suboptimal, failing to meet national health goals.
  • Individualized treatment using hemodynamic data from impedance cardiography (ICG) is proposed to enhance blood pressure (BP) control.

Purpose of the Study:

  • To quantitatively analyze clinical trials evaluating impedance cardiography (ICG) for guiding hypertension treatment.
  • To assess the effectiveness of ICG-guided therapeutic decision-making in achieving target blood pressure levels.

Main Methods:

  • A meta-analysis of five studies, including two randomized controlled trials (RCTs) and three single-arm prospective trials.
  • A total of 759 hypertensive patients were included, with ICG data used to inform treatment strategies.

Main Results:

  • ICG-guided treatment showed significant benefits in both RCTs, with an odds ratio of 2.41 favoring ICG use (p = 0.0008).
  • Success rates for achieving goal BP (<140/90 mmHg) were 67% in ICG-guided arms of RCTs and 68% in single-arm trials.

Conclusions:

  • The meta-analysis confirms the value of impedance cardiography (ICG) in guiding hypertension therapy.
  • ICG-based approaches support individualized, evidence-based, and cost-effective strategies to improve hypertension control.
Abstract

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...